Cargando…

GFPT1 deficiency in muscle leads to myasthenia and myopathy in mice

Glutamine-fructose-6-phosphate transaminase 1 (GFPT1) is the rate-limiting enzyme in the hexosamine biosynthetic pathway which yields precursors required for protein and lipid glycosylation. Mutations in GFPT1 and other genes downstream of this pathway cause congenital myasthenic syndrome (CMS) char...

Descripción completa

Detalles Bibliográficos
Autores principales:	Issop, Yasmin, Hathazi, Denisa, Khan, Muzamil Majid, Rudolf, Rüdiger, Weis, Joachim, Spendiff, Sally, Slater, Clarke R, Roos, Andreas, Lochmüller, Hanns
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121184/ https://www.ncbi.nlm.nih.gov/pubmed/29905857 http://dx.doi.org/10.1093/hmg/ddy225

Ejemplares similares

Diverse myopathological features in the congenital myasthenia syndrome with GFPT1 mutation
por: Jiang, Kaiyan, et al.
Publicado: (2022)

Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1)
por: Chen, Qiushi, et al.
Publicado: (2015)

Modulation of Agrin and RhoA Pathways Ameliorates Movement Defects and Synapse Morphology in MYO9A-Depleted Zebrafish
por: O’Connor, Emily, et al.
Publicado: (2019)

Mitochondrial Mutations Can Alter Neuromuscular Transmission in Congenital Myasthenic Syndrome and Mitochondrial Disease
por: O’Connor, Kaela, et al.
Publicado: (2023)

Targeted Therapies for Metabolic Myopathies Related to Glycogen Storage and Lipid Metabolism: a Systematic Review and Steps Towards a ‘Treatabolome’
por: Manta, A., et al.
Publicado: (2021)

GNE myopathy: from clinics and genetics to pathology and research strategies
por: Pogoryelova, Oksana, et al.
Publicado: (2018)

Modulation of the Acetylcholine Receptor Clustering Pathway Improves Neuromuscular Junction Structure and Muscle Strength in a Mouse Model of Congenital Myasthenic Syndrome
por: Spendiff, Sally, et al.
Publicado: (2020)

Presynaptic Congenital Myasthenic Syndromes: Understanding Clinical Phenotypes through In vivo Models
por: Pugliese, Alessia, et al.
Publicado: (2023)

Neuromuscular Junction Changes in a Mouse Model of Charcot-Marie-Tooth Disease Type 4C
por: Cipriani, Silvia, et al.
Publicado: (2018)

Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome
por: McMacken, Grace M, et al.
Publicado: (2019)

Biochemical and pathological changes result from mutated Caveolin-3 in muscle
por: González Coraspe, José Andrés, et al.
Publicado: (2018)

Congenital myasthenic syndrome caused by a frameshift insertion mutation in GFPT1
por: Szelinger, Szabolcs, et al.
Publicado: (2020)

Roles of GFPT2 Expression Levels on the Prognosis and Tumor Microenvironment of Colon Cancer
por: Ding, Xiaorong, et al.
Publicado: (2022)

In-depth phenotyping of lymphoblastoid cells suggests selective cellular vulnerability in Marinesco-Sjögren syndrome
por: Kollipara, Laxmikanth, et al.
Publicado: (2017)

Characterisation of a novel cardiac phenotype in patients with GFPT1 or DPAGT1 mutations
por: Lewis, Andrew, et al.
Publicado: (2014)

GFPT2/GFAT2 and AMDHD2 act in tandem to control the hexosamine pathway
por: Kroef, Virginia, et al.
Publicado: (2022)

GNE genotype explains 20% of phenotypic variability in GNE myopathy
por: Pogoryelova, Oksana, et al.
Publicado: (2019)

Identification of Cellular Pathogenicity Markers for SIL1 Mutations Linked to Marinesco-Sjögren Syndrome
por: Gatz, Christian, et al.
Publicado: (2019)

High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma
por: Gong, Yitao, et al.
Publicado: (2021)

Splicing regulation of GFPT1 muscle-specific isoform and its roles in glucose metabolisms and neuromuscular junction
por: Farshadyeganeh, Paniz, et al.
Publicado: (2023)

Inflammatory myopathy with myasthenia gravis: Thymoma association and polymyositis pathology
por: Uchio, Naohiro, et al.
Publicado: (2018)

Statin‐associated necrotizing autoimmune myopathy with concurrent myasthenia gravis
por: Frasson, Emma, et al.
Publicado: (2021)

Translocation of molecular chaperones to the titin springs is common in skeletal myopathy patients and affects sarcomere function
por: Unger, Andreas, et al.
Publicado: (2017)

Autosomal recessive variants in TUBGCP2 alter the γ-tubulin ring complex leading to neurodevelopmental disease
por: Gungor, Serdal, et al.
Publicado: (2020)

Loss of supervillin causes myopathy with myofibrillar disorganization and autophagic vacuoles
por: Hedberg-Oldfors, Carola, et al.
Publicado: (2020)

Proteomic Profiling Unravels a Key Role of Specific Macrophage Subtypes in Sporadic Inclusion Body Myositis
por: Roos, Andreas, et al.
Publicado: (2019)

Phenotypic stratification and genotype–phenotype correlation in a heterogeneous, international cohort of GNE myopathy patients: First report from the GNE myopathy Disease Monitoring Program, registry portion
por: Pogoryelova, Oksana, et al.
Publicado: (2018)

Abnormal decrement on high-frequency repetitive nerve stimulation in congenital myasthenic syndrome with GFPT1 mutations and review of literature
por: An, Ran, et al.
Publicado: (2022)

Congenital Myasthenic Syndromes or Inherited Disorders of Neuromuscular Transmission: Recent Discoveries and Open Questions
por: Nicole, Sophie, et al.
Publicado: (2017)

Identification of Candidate Protein Markers in Skeletal Muscle of Laminin-211-Deficient CMD Type 1A-Patients
por: Kölbel, Heike, et al.
Publicado: (2019)

Adult-onset Nemaline Myopathy Coexisting With Myasthenia Gravis: A Case Report
por: Cao, Lingling, et al.
Publicado: (2016)

Pembrolizumab-induced Ocular Myasthenia Gravis with Anti-titin Antibody and Necrotizing Myopathy
por: Onda, Asako, et al.
Publicado: (2019)

SARS-CoV-2 may unravel metabolic myopathy mistaken for myasthenia
por: Finsterer, Josef, et al.
Publicado: (2021)

The Case of a Glucocorticoid-Induced Myopathy & Myasthenia Gravis Combination: Is There a Border?
por: Dzherieva, Irina, et al.
Publicado: (2021)

Myopathy or Myasthenia Positive for Antibodies Against MuSK, Lrp4, and Titin
por: Finsterer, Josef, et al.
Publicado: (2020)

Mutations in gfpt1 and skiv2l2 Cause Distinct Stage-Specific Defects in Larval Melanocyte Regeneration in Zebrafish
por: Yang, Chao-Tsung, et al.
Publicado: (2007)

Glutamine-Fructose-6-Phosphate Transaminase 2 (GFPT2) Is Upregulated in Breast Epithelial–Mesenchymal Transition and Responds to Oxidative Stress
por: Wang, Qiong, et al.
Publicado: (2021)

Reply to: Myopathy in Myasthenia Positive for Antibodies Against MuSK, Lrp4, and Titin
por: Yamashita, Rika, et al.
Publicado: (2020)

Mitochondrial DNA deletions in muscle satellite cells: implications for therapies
por: Spendiff, Sally, et al.
Publicado: (2013)

Cancer‐associated fibroblast expression of glutamine fructose‐6‐phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer
por: Yang, Shuo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kq5hj8vpds7851ga2kamkg2mr0